ZEN INVESTING
zen investing
Revolutionizing Antibody Development: AlphaBind Leverages NVIDIA and AWS
AlphaBind, developed by A-Alpha Bio, employs NVIDIA and AWS technologies to enhance antibody-antigen binding predictions, aiming to revolutionize biologics development.